5 Best Low-Risk Dividend Stocks to Invest In

3. Pfizer Inc. (NYSE:PFE)

Dividend Yield as of December 7: 3.22%
Beta Value: 0.65

Pfizer Inc. (NYSE:PFE) is an American multinational pharmaceutical and biotech company. In Q3 2022, the company reported revenue of $22.6 billion, which beat analysts’ consensus by $1.5 billion. Its cash position remained strong during the quarter, as it returned $6.7 billion to shareholders in dividends. The company’s strong balance sheet and consistent dividends make it one of the best dividend stocks to buy.

Pfizer Inc. (NYSE:PFE) offers a quarterly dividend of $0.40 per share for a dividend yield of 3.22%, as recorded on December 7. The company maintains a 12-year streak of consistent dividend growth.

Credit Suisse initiated its coverage of Pfizer Inc. (NYSE:PFE) in November with an Outperform rating and a $55 price target, highlighting the company’s Covid vaccines’ success in recent quarters.

Pfizer Inc. (NYSE:PFE) was a part of 77 hedge fund portfolios in Q3 2022, up from 70 in the previous quarter, as per Insider Monkey’s database. The collective value of stakes owned by these hedge funds is over $2.4 billion.

Diamond Hill Capital mentioned Pfizer Inc. (NYSE:PFE) in its Q3 2022 investor letter. Here is what the firm has to say:

“Also among our bottom contributors were health care products manufacturer Abbott Labs, global pharmaceutical company Pfizer Inc. (NYSE:PFE), media and technology giant Alphabet, and insurance company American International Group (AIG). Although Pfizer continues to report strong performance of its core drugs, sales of its COVID vaccine and treatment have likely peaked and sales are expected to decline going forward. We remain optimistic about the company long term as we believe management is taking the company in the right direction, focusing R&D, and making strategic acquisitions with profits generated from COVID vaccine sales.”